Sbk2, a Newly Discovered Atrium-Enriched Regulator of Sarcomere Integrity

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Stem Cell Biology

Background:

• Heart development requires precise control of cardiac gene expression.
• Existing models like animals and pluripotent stem cells have aided gene discovery.
• Conditionally immortalized neonatal rat atrial myocytes (iAM-1) offer a synchronized model for studying cardiomyocyte differentiation.

Purpose of the Study:

• To identify and characterize novel, lowly expressed genes involved in cardiomyocyte differentiation.
• To leverage the unique properties of iAM-1 cells for gene discovery.
• To investigate the role of uncharacterized genes in cardio(myo)genesis.

Main Methods:

• Transcriptome analysis of iAM-1 cells during differentiation and dedifferentiation cycles.
• Filtering for cardiac-enriched, low-abundance transcripts.
• Investigating the function of identified genes, such as Sbk2, through knockdown experiments.
• Co-immunoprecipitation to identify Sbk2 interaction partners.

Main Results:

• Transcriptome analysis revealed dynamic gene expression changes during cardiomyocyte differentiation and dedifferentiation.
• Sbk2 (SH3 domain binding kinase family member 2) was identified as a cardiac-enriched, lowly expressed gene.
• Sbk2 protein is muscle-specific, atrium-enriched, and localized to cardiac sarcomeres.
• Sbk2 knockdown led to loss of sarcomeric organization and decreased sarcomeric gene expression in rat and human cardiomyocytes.
• Potential Sbk2 interaction partners involved in diverse cellular functions were identified.

Conclusions:

• iAM-1 cells are a valuable model for discovering genes with unknown roles in cardiomyocyte differentiation.
• Sbk2 is a novel regulator of atrial sarcomerogenesis.
• Sbk2 plays a critical role in maintaining sarcomeric organization during cardiomyocyte development.